| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/29/2004 | US6756033 Method for delivering benzindene prostaglandins by inhalation |
| 06/29/2004 | US6756031 One or more of: polyacrylonitrile, polyvinylacetate, cellulose acetate butyrate, nitrocellulose and polycarbonateurethane copolymers and maleic acid-styrene copolymers; a contrast agent, and a biocompatible solvent |
| 06/29/2004 | US6755814 Implantable infusion pump with level measurement |
| 06/29/2004 | US6755010 Capsules |
| 06/29/2004 | CA2366304C Novel method of treatment |
| 06/29/2004 | CA2311391C Skin protection composition |
| 06/29/2004 | CA2296726C Combination therapy |
| 06/29/2004 | CA2293815C Film-coated tablet for improved upper gastrointestinal tract safety |
| 06/29/2004 | CA2290017C Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance |
| 06/29/2004 | CA2285052C Improvements in or relating to long-acting antimicrobials |
| 06/29/2004 | CA2275392C New aqueous medicament preparations for the production of propellent gas-free aerosols |
| 06/29/2004 | CA2234936C Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine |
| 06/29/2004 | CA2164344C Tablet coating based on a melt-spun mixture of a saccharide and a polymer |
| 06/29/2004 | CA2146645C Plaster for the transdermal administration of volatile, pharmaceutically active, chemically alkaline ingredients and processes for producing the same |
| 06/29/2004 | CA2135192C Vaccinal fluid water-in-oil emulsions containing a metabolizable oil |
| 06/29/2004 | CA2131285C Pharmaceutical inhalation compositions |
| 06/29/2004 | CA2082398C Surgical implant and method incorporating chemotherapeutic agents |
| 06/27/2004 | CA2454050A1 Pharmaceutical formulae for thyroid hormones and procedures for obtaining them |
| 06/24/2004 | WO2004053056A2 Nanoparticle-based vaccine delivery system containing adjuvant |
| 06/24/2004 | WO2004052835A1 Levalbuterol salt |
| 06/24/2004 | WO2004052607A1 Method of preparing biologically active formulations |
| 06/24/2004 | WO2004052420A2 Barriers for bioactive agent-containing polymeric coatings |
| 06/24/2004 | WO2004052403A1 Preservative for ophthalmology |
| 06/24/2004 | WO2004052401A2 Compositions and methods of delivery of pharmacological agents |
| 06/24/2004 | WO2004052400A1 Pharmaceutical formulation and a method of making same |
| 06/24/2004 | WO2004052394A1 Broad-spectrum lps based vaccines of unencapsulated strains of haemophilus influenzae and other pathogenic species of gram-negative bacteria |
| 06/24/2004 | WO2004052374A1 Combination medicament |
| 06/24/2004 | WO2004052367A1 Tablet comprising efletirizine and pseudoephedrine |
| 06/24/2004 | WO2004052355A1 Use of n-chlorotaurine for treatment of oozing tissue deficiencies |
| 06/24/2004 | WO2004052354A1 Propofol-containing fat emulsions |
| 06/24/2004 | WO2004052353A2 Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid |
| 06/24/2004 | WO2004052347A1 Transmucosal and transdermal medicaments with an improved active ingredient absorption |
| 06/24/2004 | WO2004052346A1 Pharmaceutical compositions containing indistinguishable drug components |
| 06/24/2004 | WO2004052345A1 Coating composition for taste masking coating and methods for their application and use |
| 06/24/2004 | WO2004052344A1 Improved carrier system for cyclosporin pharmaceutical compositions |
| 06/24/2004 | WO2004052343A1 Controlled-release of an active substance into a high fat environment |
| 06/24/2004 | WO2004052342A1 A new oral immediated release dosage form |
| 06/24/2004 | WO2004052341A1 Adjuvant compositions containing a sugar in crystalline form and aminoalkyl glucosaminide-4-phosphate |
| 06/24/2004 | WO2004052340A1 Microparticles prepared using an ionic liquid |
| 06/24/2004 | WO2004052339A1 Ph triggered targeted controlled release systems |
| 06/24/2004 | WO2004052338A1 Body cavity washer, device for washing body cavity and method of washing body cavity |
| 06/24/2004 | WO2004052337A2 Nasal pharmaceutical preparation containing an active lipophilic liquid or gaseous ingredient |
| 06/24/2004 | WO2004052336A2 High viscosity liquid controlled delivery system and medical or surgical device |
| 06/24/2004 | WO2004052335A1 Thin film delivery systems for volatile decongestants |
| 06/24/2004 | WO2004052334A2 Drug delivery particles and methods of treating particles to improve their drug delivery capabilities |
| 06/24/2004 | WO2004052333A1 Pharmaceutical compositions for the pulmonary delivery of aztreonam |
| 06/24/2004 | WO2004052294A2 Compositions and methods related to lipid:emodin formulations |
| 06/24/2004 | WO2004052289A2 Multilayered tablet containing pravastatin and aspirin |
| 06/24/2004 | WO2004052287A2 Topical composition for heightened sensitivity |
| 06/24/2004 | WO2004052238A2 Phototherapy bandage |
| 06/24/2004 | WO2004039349A8 Pharmaceutical and cosmetic formulations |
| 06/24/2004 | WO2004039320A3 STEREOISOMERS OF p-HYDROXY-MILNACIPRAN, AND METHODS OF USE THEREOF |
| 06/24/2004 | WO2004037899A3 Chitosan pellets |
| 06/24/2004 | WO2004037223A3 Liposome-forming compositions |
| 06/24/2004 | WO2004035020A3 Controlled release preparation |
| 06/24/2004 | WO2004028570A3 A method for treating severe tinnitus |
| 06/24/2004 | WO2004022002A3 Combined immediate release and extended release analgesic composition |
| 06/24/2004 | WO2004021976A3 New polymers and applications |
| 06/24/2004 | WO2004017903A3 Methods for treating fungal infections |
| 06/24/2004 | WO2004014304A3 Electrospun amorphous pharmaceutical compositions |
| 06/24/2004 | WO2004014156B1 A chemical carrier based on a beta-limit dextrin |
| 06/24/2004 | WO2004009665A3 Dendrimers as molecular translocators |
| 06/24/2004 | WO2003105724A3 Novel maxi-k channel blockers, methods of use and process for making the same |
| 06/24/2004 | WO2003072056A3 Intranasal administration of mc4-r agonists |
| 06/24/2004 | WO2003047589A8 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 06/24/2004 | WO2002040056A9 Carrageenan viscoelastics for ocular surgery |
| 06/24/2004 | WO2002036072A3 Method for short-term and long-term drug dosimetry |
| 06/24/2004 | US20040122554 Container and method for dispensing transdermal dosage forms |
| 06/24/2004 | US20040122529 Prosthetic foot with tunable performance |
| 06/24/2004 | US20040122165 Hydrogel-forming system with hydrophobic and hydrophilic components |
| 06/24/2004 | US20040122106 rapidly disintegrates in the oral cavity without water and has a practical hardness; comprises a water soluble active ingredient, D-mannitol in the form of crystals or fine particles and crospovidone |
| 06/24/2004 | US20040122105 Transdermal compositions |
| 06/24/2004 | US20040122104 has an enteric coating that delays the release of milnacipran within the stomach, thereby avoiding side effects such as nausea, vomiting, bleeding due to irritation of the gastric mucosa, sleep disturbance, headache etc |
| 06/24/2004 | US20040122081 Intravenous formulation for a taxoid antitumor agent as a two-vial kit with the taxoid, solvent and buffer in one vial and cosolvent and buffer in the other; mixing prior to administration; improved solubility, stability and oxidation resistance |
| 06/24/2004 | US20040122071 Fluconazole, a compound selected from a group consisting of fatty acid, fatty alcohol, higher fatty acid ester and lower alcohol and a base; favorable absorption and delivery through the human skin; low skin stimulation; stability; spreading |
| 06/24/2004 | US20040122065 Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or buccally |
| 06/24/2004 | US20040122064 Enzyme inhibitors of both wild type and mutant variants of HIV reverse transcriptase, particularly resistant varieties; e.g.,N-{4-[(acetylamino)sulfonyl]-2-methylphenyl}-2-[4-chloro-2-(3-cyano-5-methylbenzoyl)phenoxy]acetamide |
| 06/24/2004 | US20040122048 Stabilized pharmaceutical composition containing basic excipients |
| 06/24/2004 | US20040121987 Liposomal analgesic formulation and use |
| 06/24/2004 | US20040121958 Methods of alleviating neuropathic pain |
| 06/24/2004 | US20040121944 Cyclosporin-based pharmaceutical compositions |
| 06/24/2004 | US20040121486 Controlled release device and method using electrothermal ablation |
| 06/24/2004 | US20040121302 for photo-processing of blood products, pharmaceuticals, injectables and vaccines using non-laser light source(s); for inactivating pathogens |
| 06/24/2004 | US20040121154 oily oxidation-sensitive or else readily volatile active component is distributed homogeneously and discretely in a matrix and encapsulated without a core with at least one water-soluble polysaccharide as film forming agent; dosage form |
| 06/24/2004 | US20040121032 Burnet extract |
| 06/24/2004 | US20040121028 Plant based agents as bioavailability / bioefficacy enhancers for drugs and nutraceuticals |
| 06/24/2004 | US20040121019 Particles comprising a biopolymer which is degradable under the effect of an electromagnetic wave as emitted by a solar radiation |
| 06/24/2004 | US20040121018 mixing chymotrypsin with polysiloxane, then polymerizing to form particle |
| 06/24/2004 | US20040121016 Functional composition, liquid composition and application method and apparatus therefor |
| 06/24/2004 | US20040121015 active substanece administered to a high fat use environment such as the human gastrointestinal tract following a high fat meal; active-substance-containing core and an asymmetric polymeric coating (cellulose acetates) |
| 06/24/2004 | US20040121014 Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| 06/24/2004 | US20040121013 Novel formulation |
| 06/24/2004 | US20040121012 Sustained release matrix for high-dose insoluble drugs |
| 06/24/2004 | US20040121011 Methods for making and delivering Rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof |
| 06/24/2004 | US20040121010 once-a-day oral milnacipran pulsatile release when administered orally, releases drug in spaced apart "pulses", this delivery profile reduces gastrointestinal side effects by minimizing exposure of the internal mucosal surfaces to the drug |
| 06/24/2004 | US20040121009 Method of modifying the release profile of sustained release compositions |
| 06/24/2004 | US20040121008 Process for producing sustained release preparation |
| 06/24/2004 | US20040121007 spray-granulating the bisphosphonate, a part of filler and disintegrant with a solution of the binder in purified water, drying the spray granulated material, screening, mixing remaining filler, lubricants, flow controller, compressing into tablet |
| 06/24/2004 | US20040121006 Utilization of spray-dried powder containing sugar alcohol |
| 06/24/2004 | US20040121005 Porous COX-2 inhibitor matrices and methods of manufacture thereof |